Skip to main content
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1984 Jun;60(5):504–513.

New drugs, more complications--old drugs, new complications: drug-related sequelae of neonatal intensive care.

E G Kassner
PMCID: PMC1911752  PMID: 6587926

Full text

PDF
504

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloss R. S., Aranda J. V., Beardmore H. E. Congenital diaphragmatic hernia: pathophysiology and pharmacologic support. Surgery. 1981 Apr;89(4):518–524. [PubMed] [Google Scholar]
  2. Callahan J., Haller J. O., Cacciarelli A. A., Slovis T. L., Friedman A. P. Cholelithiasis in infants: association with total parenteral nutrition and furosemide. Radiology. 1982 May;143(2):437–439. doi: 10.1148/radiology.143.2.6803294. [DOI] [PubMed] [Google Scholar]
  3. Cole R. B., Abman S., Aziz K. U., Bharati S., Lev M. Prolonged prostaglandin E1 infusion: histologic effects on the patent ductus arteriosus. Pediatrics. 1981 Jun;67(6):816–819. [PubMed] [Google Scholar]
  4. Dekel S., Francis M. J. Cortical hyperostosis after administration of prostaglandin E. J Pediatr. 1981 Sep;99(3):500–501. doi: 10.1016/s0022-3476(81)80364-2. [DOI] [PubMed] [Google Scholar]
  5. Dillard R. G., Crowe J. E., Sumner T. E. Pancuronium and abnormal abdominal roentgenograms. Am J Dis Child. 1980 Sep;134(9):821–823. doi: 10.1001/archpedi.1980.02130210005002. [DOI] [PubMed] [Google Scholar]
  6. Goldsmith M. A., Bhatia S. S., Kanto W. P., Jr, Kutner M. H., Rudman D. Gluconate calcium therapy and neonatal hypercalciuria. Am J Dis Child. 1981 Jun;135(6):538–543. doi: 10.1001/archpedi.1981.02130300038014. [DOI] [PubMed] [Google Scholar]
  7. Green T. P., Thompson T. R., Johnson D. E., Lock J. E. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N Engl J Med. 1983 Mar 31;308(13):743–748. doi: 10.1056/NEJM198303313081303. [DOI] [PubMed] [Google Scholar]
  8. Green T. P., Thompson T. R., Johnson D., Lock J. E. Furosemide use in premature infants and appearance of patent ductus arteriosus. Am J Dis Child. 1981 Mar;135(3):239–243. doi: 10.1001/archpedi.1981.02130270031011. [DOI] [PubMed] [Google Scholar]
  9. Hufnagle K. G., Khan S. N., Penn D., Cacciarelli A., Williams P. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics. 1982 Sep;70(3):360–363. [PubMed] [Google Scholar]
  10. Hufnagle K. G., Khan S. N., Penn D., Cacciarelli A., Williams P. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Pediatrics. 1982 Sep;70(3):360–363. [PubMed] [Google Scholar]
  11. Kopecky K., Cohen M., Schreiner R. Therapeutic neuromuscular paralysis in neonates: characteristic radiographic features. AJR Am J Roentgenol. 1982 Jul;139(1):25–30. doi: 10.2214/ajr.139.1.25. [DOI] [PubMed] [Google Scholar]
  12. Merten D. F., Grossman H. Intestinal obstruction associated with cholestyramine therapy. AJR Am J Roentgenol. 1980 Apr;134(4):827–828. doi: 10.2214/ajr.134.4.827. [DOI] [PubMed] [Google Scholar]
  13. Metlay L. A., Klionsky B. L. An unusual gastric bezoar in a newborn: polystyrene resin and Candida albicans. J Pediatr. 1983 Jan;102(1):121–123. doi: 10.1016/s0022-3476(83)80307-2. [DOI] [PubMed] [Google Scholar]
  14. Nagaraj H. S., Sandhu A. S., Cook L. N., Buchino J. J., Groff D. B. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants. J Pediatr Surg. 1981 Dec;16(6):1003–1007. doi: 10.1016/s0022-3468(81)80865-2. [DOI] [PubMed] [Google Scholar]
  15. Portuguez-Malavasi A., Aranda J. V. Antacid bezoar in a newborn. Pediatrics. 1979 Apr;63(4):679–680. [PubMed] [Google Scholar]
  16. Ringel R. E., Brenner J. I., Haney P. J., Burns J. E., Moulton A. L., Berman M. A. Prostaglandin-induced periostitis: a complication of long-term PGE1 infusion in an infant with congenital heart disease. Radiology. 1982 Mar;142(3):657–658. doi: 10.1148/radiology.142.3.7199748. [DOI] [PubMed] [Google Scholar]
  17. Siegle R. L. Neonatal gasless abdomen: another cause. AJR Am J Roentgenol. 1979 Sep;133(3):522–523. doi: 10.2214/ajr.133.3.522. [DOI] [PubMed] [Google Scholar]
  18. Sone K., Tashiro M., Fujinaga T., Tomomasa T., Tokuyama K., Kuroume T. Long-term low-dose prostaglandin E1 administration. J Pediatr. 1980 Nov;97(5):866–867. doi: 10.1016/s0022-3476(80)80291-5. [DOI] [PubMed] [Google Scholar]
  19. Strauss A., Modanlou H. D., Gyepes M., Wittner R. Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant. Am J Dis Child. 1982 Oct;136(10):934–936. doi: 10.1001/archpedi.1982.03970460064014. [DOI] [PubMed] [Google Scholar]
  20. Ueda K., Saito A., Nakano H., Aoshima M., Yokota M., Muraoka R., Iwaya T. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr. 1980 Nov;97(5):834–836. doi: 10.1016/s0022-3476(80)80282-4. [DOI] [PubMed] [Google Scholar]
  21. Whitington P. F., Black D. D. Cholelithiasis in premature infants treated with parenteral nutrition and furosemide. J Pediatr. 1980 Oct;97(4):647–649. doi: 10.1016/s0022-3476(80)80033-3. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES